Laughing Water Capital's Top 5 Positions For Q2 2025

The provided text outlines specific investment theses for several companies: Lifecore Biomedical is positioned for margin expansion and acquisition, NextNav for significant appreciation post-FCC approval, SECURE Waste Infrastructure for downside protection and high equity CAGR, and Vistry Group for re-rating and growth driven by government funding. These opportunities are presented by Laughing Water Capital, a concentrated, long-biased investment partnership that targets undervalued or misunderstood companies with temporary problems, seeking to unlock value through operational improvements and multiple expansion via incentivized management teams.

Analysis

Investment theses presented by Laughing Water Capital highlight several companies positioned for significant, catalyst-driven upside. The firm's strategy focuses on misunderstood or temporarily troubled businesses where incentivized management teams can drive operational improvements and valuation multiple expansion. For Lifecore Biomedical (LFCR), the primary drivers are margin expansion and its potential as an acquisition target at a premium to its current trading price. NextNav (NN) is identified as a compelling case based on an anticipated favorable FCC spectrum approval, which is supported by national security tailwinds and could unlock substantial value upon monetization. SECURE Waste Infrastructure is presented as a defensive investment offering recurring cash flows and downside protection, augmented by an aggressive share buyback program and the potential for a 30-40% equity CAGR upon a valuation re-rating. Lastly, Vistry Group is framed as an undervalued entity recovering from accounting issues, with government funding expected to fuel growth and lead to a significant recovery in operating profit and its trading multiple.

Key Decisions for Investors

• Investors should evaluate these catalyst-driven opportunities by monitoring specific milestones, such as the FCC spectrum approval for NextNav and potential M&A developments for Lifecore Biomedical.
• Given the focus on undervalued companies with temporary problems, it is prudent to assess the potential for a prolonged recovery period and be prepared for volatility, as the theses for SECURE Waste and Vistry Group hinge on valuation re-ratings over time.
• A critical due diligence step is to scrutinize the management teams of these companies, specifically their equity ownership and incentive structures, as this alignment is a core tenet of the presented strategy for unlocking value.